In contrast to the relative extensive pharmacological characterization performed for other renal ClC proteins, such as ClC-K chloride channels [100,101,102], no ClC-5 high-affinity ligand is currently available; thus, the identification of drugs that specifically inhibit ClC-5 to slow down or to prevent cyst expansion is an unmet need. Here, CLCN5 is linked to cyst.